Clinical Trial Update: Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

An early-phase (Phase 1) study of SYN608 for advanced or metastatic solid tumors is not yet recruiting. The indications include ovarian cancer and breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• SYN608

Snippet

Sponsor: Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | Conditions: Advanced Solid Cancer, Metastatic Solid Tumor | Phase 1 | Status: NOT_YET_RECRUITING